Senti Biosciences, Inc.

Historical 13F Holders

Symbol
SNTI
CUSIP
81726A209
All holders as of
Q3 2026
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 81726A209 since 12/18/2024, largest first.

Filer % of Class Filed
Celadon Partners SPV 24 13D/A
45.0% 1/20/2026
Event 1/19/2026
New Enterprise Associates 15, L.P. 13D/A
12.1% 3/31/2026
Event 3/27/2026
Nantahala Capital Management, LLC 13G/A
8.1% 5/15/2025
Event 3/31/2025
Under 5%, checked the "5 percent or less" box, or amended by a later filing (2)
Armistice Capital, LLC 13G/A
4.99% 5/15/2025
Event 3/31/2025
Nantahala Capital Partners Limited Partnership 13G/A 1.9% 5/15/2025
Event 3/31/2025

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 1 3.78 M $1.18M
2026 Q2 1 3.78 M $4.15M
2026 Q1 16 5.64 M $4.58M
2025 Q4 15 5.61 M $5.84M
2025 Q3 15 5.61 M $7.91M
2025 Q2 15 6.48 M $13.7M
2025 Q1 16 5.66 M $19.0M
2024 Q4 16 667 k $2.34M
2024 Q3 13 764 k $1.73M